Home › Myelodysplastic Syndromes › North Carolina › Durham

Pag-aaral pangklinika para sa Myelodysplastic Syndromes sa Durham, NC

14 pag-aaral para sa Myelodysplastic Syndromes ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Durham (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Nagre-recruitPhase 2

Duke University Medical Center, Durham
UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05564390

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

Nagre-recruitPhase 2

Duke University Medical Center, Durham

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06577441

Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS

Nagre-recruitPhase 1

University of North Carolina at Chapel Hill, Chapel Hill · 10 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT06846606

Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation

Nagre-recruitPhase 3

Unc Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06465953

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Nagre-recruitPhase 1/2

Duke University Medical Center, Durham
UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi ang layo

Hanggang edad 22 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04726241

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

Nagre-recruitPhase 1

University of North Carolina at Chapel Hill, Chapel Hill · 10 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT06656494

Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)

Nagre-recruitPhase 1/2

Duke Cancer Institute, Durham

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT05308264

Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

Nagre-recruitPhase 1/2

Research Site, Durham
Research Site, Chapel Hill · 10 mi ang layo

Edad 16 pataas · Lahat ng kasarian · Na-update Hul 20, 2026 · NCT07155226

Registry of Older Patients With Cancer

Nagre-recruitObservasyonal na pag-aaral

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi ang layo

Edad 65 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT01137825

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Nagre-recruitPhase 2/3

Duke University, Durham

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 30, 2026 · NCT04256317

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Nagre-recruitPhase 1/2

Duke University, Durham
UNC Hospital, Chapel Hill · 10 mi ang layo

Edad 12 pataas · Lahat ng kasarian · Na-update Mar 24, 2026 · NCT04988555

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Nagre-recruitPhase 1

Duke Cancer Center, Durham

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 16, 2026 · NCT05143996

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi ang layo

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

Nagre-recruitObservasyonal na pag-aaral

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi ang layo

Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Okt 27, 2025 · NCT01137643

Pag-aaral para sa Myelodysplastic Syndromes sa ibang lungsod

Iba pang pag-aaral sa Durham

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.